ESSA Pharma Inc.
EPIX · NASDAQ
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Market Cap | $268,319 | $136,237 | $80,150 | $307,843 |
| - Cash | $103,710 | $33,702 | $57,076 | $137,825 |
| + Debt | $329 | $80 | $210 | $331 |
| Enterprise Value | $164,939 | $102,615 | $23,283 | $170,349 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$91 | -$118 | -$122 | -$109 |
| % Margin | – | – | – | – |
| EBITDA | -$28,452 | -$26,455 | -$35,080 | -$36,708 |
| % Margin | – | – | – | – |
| Net Income | -$28,543 | -$26,582 | -$35,103 | -$36,805 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.64 | -0.6 | -0.8 | -0.96 |
| % Growth | -6.7% | 25% | 16.7% | – |
| Operating Cash Flow | -$22,716 | -$19,782 | -$28,704 | -$25,416 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$22,716 | -$19,782 | -$28,704 | -$25,416 |